本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enliven Treateutics

53.25
-1.1800-2.17%
成交量:40.03萬
成交額:2,137.90萬
市值:39.02億
市盈率:-31.78
高:54.50
開:54.32
低:52.98
收:54.43
52周最高:62.32
52周最低:14.79
股本:7,327.08萬
流通股本:6,172.59萬
量比:0.50
換手率:0.65%
股息:- -
股息率:- -
每股收益(TTM):-1.6753
每股收益(LYR):-1.8300
淨資產收益率:-15.31%
總資產收益率:-11.00%
市淨率:4.36
市盈率(LYR):-29.10

資料載入中...

2025/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/10/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities